Diagnosis and Management of Small Lymphocytic Lymphoma (SLL)Versus Chronic Lymphocytic Leukemia

Authors

Anthea Peters, MD
Robert Puckrin, MD

Abstract

Add later

References

add later

Downloads

Published

2025-05-05

How to Cite

1.

Peters A, Puckrin R. Diagnosis and Management of Small Lymphocytic Lymphoma (SLL)Versus Chronic Lymphocytic Leukemia. Can Hematol Today [Internet]. 2025 May 5 [cited 2025 May 30];4(1):48-52. Available from: https://canadianhematologytoday.com/article/view/4-1-Peters_et_al

Download Citation

Issue

Volume 4, Issue 1, Spring 2025

Section

Articles

License

Copyright (c) 2025 Canadian Hematology Today

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Robert Puckrin, MD, FRCPC, Douglas A. Stewart, MD, FRCPC, Controversies and current practices in CNS relapse of diffuse large B-cell lymphoma , Canadian Hematology Today: Volume 2, Issue 1, March 2023
Anthea Peters, MD, FRCPC, Emerging therapeutic agents in the treatment of relapsed or refractory diffuse large B cell lymphoma , Canadian Hematology Today: Volume 1, Issue 1, March 2022
Anthea Peters, MD, MSc, FRCPC, Sheri L. Koshman, BScPharm, PharmD, ACPR, FCSHP, Hypertension as a Cardiovascular Toxicity of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia , Canadian Hematology Today: Special Supplement, Spring 2025
Anthea Peters, MD, FRCPC, Safety and tolerability of Bruton's tyrosine kinase inhibitors in the treatment of Waldenström macroglobulinemia , Canadian Hematology Today: Special Supplement, June 2022